-
Product Insights
Likelihood of Approval Analysis for Polyneuropathies
Overview How likely is it that the drugs in Polyneuropathies will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Polyneuropathies Overview Polyneuropathies represent a group of disorders characterized by damage or dysfunction...
-
Product Insights
Likelihood of Approval Analysis for Somatic Pain
Overview How likely is it that the drugs in Somatic Pain will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Somatic Pain Overview Somatic pain refers to a type of pain that...
-
Product Insights
Likelihood of Approval Analysis for Substance (Drug) Abuse
Overview How likely is it that the drugs in Substance (Drug) Abuse will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Substance (Drug) Abuse Overview Substance abuse refers to the problematic pattern...
-
Product Insights
Likelihood of Approval Analysis for Inflammatory Pain
Overview How likely is it that the drugs in Inflammatory Pain will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Inflammatory Pain Overview Inflammatory pain stems from the body's response to injury,...
-
Product Insights
Likelihood of Approval Analysis for Mixed Pain (Nociceptive Pain/Neuropathic Pain)
Overview How likely is it that the drugs in Mixed Pain (Nociceptive Pain/Neuropathic Pain) will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Mixed Pain (Nociceptive Pain/Neuropathic Pain) Overview Mixed pain involves...
-
Product Insights
Likelihood of Approval Analysis for Nociceptive Pain
Overview How likely is it that the drugs in Nociceptive Pain will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Nociceptive Pain Overview Nociceptive pain is a type of pain caused by...
-
Product Insights
Likelihood of Approval Analysis for Constipation
Overview How likely is it that the drugs in Constipation will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Constipation Overview Constipation refers to infrequent bowel movements or difficulty passing stool, often...
-
Product Insights
Likelihood of Approval Analysis for Esophagitis
Overview How likely is it that the drugs in Esophagitis will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Esophagitis Overview Esophagitis is inflammation of the esophagus, often triggered by acid reflux,...
-
Product Insights
Likelihood of Approval Analysis for Angioedema
Overview How likely is it that the drugs in Angioedema will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Angioedema Overview Angioedema, characterized by non-pitting edema affecting various tissues, can become life-threatening...
-
Product Insights
Likelihood of Approval Analysis for Cytopenia
Overview How likely is it that the drugs in Cytopenia will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Cytopenia Overview Cytopenia is characterized by a reduction in blood cell numbers, encompassing...